(−)-JQ1 – 10 mg

Brand:
Cayman
CAS:
1268524-71-5
Storage:
-20
UN-No:
Non-Hazardous - /

The bromodomain and extra terminal domain (BET) family of proteins, including BRD2, BRD3, and BRD4, play a key role in many cellular processes, including inflammatory gene expression, mitosis, and viral/host interaction by controlling the assembly of histone acetylation-dependent chromatin complexes. (±)-JQ1 displaces BET proteins from chromatin by competitively binding to the acetyl-lysine recognition pocket of BET bromodomains.{19044,28490} The (−)-JQ1 stereoisomer has no appreciable affinity to BET bromodomains, whereas enantiomerically pure (+)-JQ1 binds to BRD4 bromodomains 1 and 2 with Kd values of ~50 and 90 nM, respectively.{19044}  

 

Available on backorder

SKU: 11232 - 10 mg Category:

Description

The inactive stereoisomer of a selective BET bromodomain inhibitor


Formal name: (6R) 4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetic acid, 1,1-dimethylethyl ester

Synonyms: 

Molecular weight: 457

CAS: 1268524-71-5

Purity: ≥98%

Formulation: A crystalline solid


Product Type|Biochemicals||Research Area|Epigenetics, Transcription, & Translation|Readers|Bromodomains